Tuesday, November 17, 2015 4:35:28 PM
This project aims to provide annotated and assembled genomes for 3,000 bacteria and 500 viruses as part of a new eResource
The project is split into two parts:
NCTC 3000: A joint collaboration between Public Health England, Pacific Biosciences and the Wellcome Trust Sanger Institute to complete the sequencing of 3,000 bacterial strains from PHE's National Collection of Type Cultures (NCTC) using Pacific Biosciences' Single Molecule, Real-Time (SMRT) sequencing technology.
NCPV 500: A collaboration between PHE and Sanger to produce 500 viral genomes from PHE's National Collection of Pathogenic Viruses (NCPV) using the Illumina sequencing platform.
Collectively, the data generated will be housed in a publically accessible web-based eResource that integrates metadata and genome sequences for type and reference strains of biomedically important bacterial and viral pathogens. This resource will integrate accession, taxonomy and authentication information with publications, genome sequences, comparative analysis databases and other resources at EMBL and NCBI.
This is a community resource project. Data will be available from here, and from the NCTC. We will submit assembled, annotated sequences to the International Sequence Databases as they become available. We request that you cite this webpage in any publication using the data, and would appreciate it if you contact us to discuss the use of this data.
Data Downloads
•Download annotated assemblies#
•BLAST server
Please note: these are pre-submission assemblies that should not be treated as final versions. Assemblies contain both chromosomal and plasmid contigs.
Background
The Wellcome Trust Sanger Institute will generate PacBio sequencing data and provide assembled and annotated genomes for the 3,000 bacteria from the NCTC collection.
The NCTC is one of the world's premier collections for bacterial strains, but most bacteria in NCTC currently have no genome references. Biological Resource Centres, such as NCTC and NCPV, are a vital part of the infrastructure underpinning life sciences, providing biomaterials of known provenance. Type and reference strains act as landmarks for mapping microbial diversity and measuring unique changes in properties and patterns of infection and response to clinical interventions. Combining reference genomes with the wealth of historical and biological information existing for these strains will generate a data set of enormous value for basic and clinical microbiology.
Pacific Biosciences' Single Molecule, Real-Time (SMRT) Sequencing technology achieves very long reads and high consensus accuracy, greatly improving the ability to finish bacterial genomes. And, because the technology can directly detect base modifications, the epigenomes for bacteria can also be obtained with no additional data acquisition, and this data will also be provided.
NCTC Strains
As bacterial strains from the collection progress through the project, links to the raw sequence data, epigenome data and annotated assemblies will appear here.
Current Statistics
•Number of species sequenced: 158
•Number of samples:719
•Number of samples manually assembled:298
•Number of samples automatically assembled:81
http://www.sanger.ac.uk/resources/downloads/bacteria/nctc/#t_2
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM